Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Jazz Pharmaceuticals plc shares valued at $548,250 were sold by Patil Neena M on May 03 ’24. At $109.65 per share, Patil Neena M sold 5,000 shares. The insider’s holdings dropped to 36,629 shares worth approximately $3.89 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Carr Patricia sold 1,768 shares, netting a total of over 206,821 in proceeds. Following the sale of shares at $116.98 each, the insider now holds 6,596 shares.
Before that, Carr Patricia had sold 1,936 shares from its account. In a trade valued at $231,628, the SVP, Chief Accounting Officer traded Jazz Pharmaceuticals plc shares for $119.64 each. Upon closing the transaction, the insider’s holdings decreased to 1,936 shares, worth approximately $0.89 million.
As published in their initiating research note from Goldman on June 05, 2024, Jazz Pharmaceuticals plc [JAZZ] has been a Buy and the price target has been revised to $169. Analysts at Robert W. Baird started covering the stock with ‘”an Outperform”‘ outlook in a report released in early January. As of November 27, 2023, UBS has decreased its “Buy” rating to a “Neutral” for JAZZ. Earlier on September 29, 2023, Raymond James initiated its rating. Their recommendation was “a Mkt perform” for JAZZ stock.
Analyzing JAZZ Stock Performance
During the last five days, there has been a surge of approximately 0.82%. Over the course of the year, Jazz Pharmaceuticals plc shares have dropped approximately -13.56%. Shares of the company reached a 52-week high of $134.17 on 02/26/24 and a 52-week low of $103.01 on 05/02/24. A 50-day SMA is recorded $110.36, while a 200-day SMA reached $122.14. Nevertheless, trading volume fell to 0.81 million shares from 0.76 million shares the previous day.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 105.49, which, if violated, would cause prices to drop to 104.65. In the upper region, resistance lies at 107.21. The next price resistance is at 108.09. RSI (Relative Strength Index) is 45.11 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.15, which suggests the price will decrease in the coming days. Percent R is at 56.49%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
